04/22/2014 - 6:20am

The Pharmacy Technician Certification Board announced that Certified Pharmacy Technicians eligible to recertify are now required to complete one hour of continuing education in patient safety, in addition to the already required hour of law CE, as part of 20 hours of CE needed for recertification.

04/22/2014 - 6:11am

Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

04/21/2014 - 1:07pm

ABC News will be hosting a live twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat.

04/21/2014 - 12:48pm

Walgreens on Monday announced that it is now offering expanded travel health services, including immunizations and consultations, to support the nearly 60 million annual planned trips by U.S. residents venturing outside the country.

04/21/2014 - 12:42pm

Lupin on Monday announced the appointment of Theresa Stevens as chief corporate development officer for its global operations.

04/21/2014 - 11:03am

Pfizer is making a bid of $100.8 billion (£60 billion) for Astra Zeneca, according to a report in the Sunday Times, published Sunday.

04/21/2014 - 10:55am

Boehringer Ingelheim Pharmaceuticals has announced that the Food and Drug Administration and European Commission have granted Orphan Drug Designation to volasertib for acute myeloid leukemia.

04/21/2014 - 10:51am

GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia for whom fludarabine-based therapy is considered inappropriate.

04/21/2014 - 10:35am

MD Science Lab on Monday launched a new personal lubricant called Swiss Navy Sensitive Skin.